MC2 Therapeutics A/S Completes Enrollment of EU Phase 3 Head-to-Head Study in Patients With Plaque Psoriasis Treated With MC2-01 PADTM Cream
Topline data are expected in Q4 2019 COPENHAGEN, Denmark–(BUSINESS WIRE)–MC2 Therapeutics A/S, a late clinical-stage pharmaceutical company focused on topical…